Vyriad is a startup based in the United States, most recent round Series B, 1 tracked investor.
Based in the United States, Vyriad is a startup founded in 2014. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Vyriad is a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.